Shares of Align Technology (ALGN) are soaring 5.07% in intraday trading on Wednesday, as investors react positively to news regarding the company's Invisalign Palatal Expander System. The dental equipment maker has announced that its innovative product has been notified as a Class B medical device by Malaysian medical authorities.

This regulatory milestone in Malaysia represents a significant step forward for Align Technology in the Asian market. Class B medical devices are typically those with medium risk, and this classification suggests that the Invisalign Palatal Expander System meets important safety and efficacy standards in Malaysia. The news likely boosted investor confidence in the company's international growth prospects and its ability to expand its product offerings in key markets.

The surge in Align Technology's stock price reflects the market's optimism about the potential impact of this development on the company's future sales and market penetration in Southeast Asia. As Align continues to innovate and gain regulatory approvals for its products globally, investors appear to be betting on the company's long-term growth potential in the orthodontics and dental alignment industry.